Seong Huan Choi

Dr. Seong Huan Choi


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2021 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
JBJang-Ho Bae
Jang-Ho Bae
SWSUNGIL WOO
SUNGIL WOO
JLJoongyub Lee
Joongyub Lee
SPSang-Don Park
Sang-Don Park
SKSung Woo Kwon
Sung Woo Kwon
WLWon Kyung Lee
Won Kyung Lee
Background: Self-management of lifestyle and cardiovascular disease risk factors is challenging in older patients with coronary heart disease (CHD). SMS text messaging could be a potential support tool for self-management and the most affordable and accessible method through a mobile phone. High-quality evidence had been lacking, and previous studies evaluated the effects of SMS text messaging on the subjective measures of short-term outcomes. Recently, a large-sized randomized controlled trial in Australia reported promising findings on the objective measures upon 6-month follow-up. However, an examination of the effectiveness of such interventions in an Asian population with unique demographic characteristics would be worthwhile. Objective: This study examined the effectiveness of a 1-way SMS text messaging program to modify the lifestyle and cardiovascular disease risk factors of patients who underwent the first percutaneous coronary intervention (PCI). Methods: A parallel, single-blinded, 1:1 random allocation clinical trial was conducted with 879 patients treated through PCI. They were recruited during hospital admission from April 2017 to May 2020 at 2 university hospitals in the Republic of Korea. In addition to standard care, the intervention group received access to a supporting website and 4 SMS text messages per week for 6 months regarding a healthy diet, physical activity, smoking cessation, and cardiovascular health. Random allocation upon study enrollment and SMS text messaging after hospital discharge were performed automatically using a computer program. The coprimary outcomes were low-density-lipoprotein cholesterol (LDL-C), systolic blood pressure (SBP), and BMI. The secondary outcomes were change in lifestyle and adherence to the recommended health behaviors. Results: Of the eligible population, 440 and 439 patients who underwent PCI were assigned to the intervention and control groups, respectively. The 1-way SMS text messaging program significantly enhanced physical activity (P=.02), healthy diet (P<.01), and medication adherence (P<.04) among patients with CHD. Hence, more people were likely to control their cardiovascular disease risk factors per the recommendations. The intervention group was more likely to control all 5 risk factors by 62% (relative risk 1.62, 95% CI 1.05-2.50) per the recommendations. On the other hand, physiological measures of the primary outcomes, including LDL-C levels, SBP, and BMI, were not significant. Most participants found the SMS text messaging program useful and helpful in motivating lifestyle changes. Conclusions: Lifestyle-focused SMS text messages were effective in the self-management of a healthy diet, exercise, and medication adherence, but their influence on the physiological measures was not significant. One-way SMS text messages can be used as an affordable adjuvant method for lifestyle modification to help prevent the recurrence of cardiovascular disease. Trial Registration: Clinical Research Information Service (CRiS) KCT0005087; https://cris.nih.go.kr/cris/search/detailSearch.do/19282

1 January 2021 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
GYGwang-Seok Yoon
Gwang-Seok Yoon
SCSeong Huan Choi
Seong Huan Choi
SWSUNGIL WOO
SUNGIL WOO
YBYong-Soo Baek
Yong-Soo Baek
SPSang-Don Park
Sang-Don Park
SKSung Woo Kwon
Sung Woo Kwon
Yoon GS, et al. J Korean Med Sci. 2021 May;36(19):e131. https://doi.org/10.3346/jkms.2021.36.e131

16 October 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GYGwang-Seok Yoon
Gwang-Seok Yoon
SASung Gyun Ahn
Sung Gyun Ahn
SWSUNGIL WOO
SUNGIL WOO
MYMyeong Ho Yoon
Myeong Ho Yoon
MLMan Jong Lee
Man Jong Lee
KSKyoung-Woo Seo
Kyoung-Woo Seo
The index of microcirculatory resistance (IMR) is a simple method that can measure microvascular function after primary percutaneous coronary intervention (PCI) in patients with ST-segment Elevation Myocardial Infarction (STEMI). This study is to find out whether IMR predicts clinical long-term outcomes in STEMI patients. A total of 316 patients with STEMI who underwent primary PCI from 2005 to 2015 were enrolled. The IMR was measured using pressure sensor/thermistor-tipped guidewire after primary PCI. The primary endpoint was the rate of death or hospitalization for heart failure (HF) over a mean follow-up period of 65 months. The mean corrected IMR was 29.4 ± 20.0. Patients with an IMR > 29 had a higher rate of the primary endpoint compared to patients with an IMR ≤ 29 (10.3% vs. 2.1%, p = 0.001). During the follow-up period, 13 patients (4.1%) died and 6 patients (1.9%) were hospitalized for HF. An IMR > 29 was associated with an increased risk of death or hospitalization for HF (OR 5.378, p = 0.004). On multivariable analysis, IMR > 29 (OR 3.962, p = 0.022) remained an independent predictor of death or hospitalization for HF with age (OR 1.048, p = 0.049) and symptom-to-balloon time (OR 1.002, p = 0.049). High IMR was an independent predictor for poor long-term clinical outcomes in STEMI patients after primary PCI.

1 January 2021 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
SCSeong Huan Choi
Seong Huan Choi
HJHo-Jun Jang
Ho-Jun Jang
YSYoung Ju Suh
Young Ju Suh
SPSang-Don Park
Sang-Don Park
POPyung Chun Oh
Pyung Chun Oh
SKSung Woo Kwon
Sung Woo Kwon
Choi SH, et al. Yonsei Med J. 2021 Oct;62(10):877-884. https://doi.org/10.3349/ymj.2021.62.10.877

1 January 2024 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
SCSeong Huan Choi
Seong Huan Choi
YLYeong Chan Lee
Yeong Chan Lee
YBYong-Soo Baek
Yong-Soo Baek
Choi SH, et al. Korean Circ J. 2024 Jul;54:e90. https://doi.org/10.4070/kcj.2024.0073

29 March 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SCSeong Huan Choi
Seong Huan Choi
SASung Gyun Ahn
Sung Gyun Ahn
MYMyeong Ho Yoon
Myeong Ho Yoon
KSKyoung-Woo Seo
Kyoung-Woo Seo
KLKi-Jeung Lee
Ki-Jeung Lee
SWSUNGIL WOO
SUNGIL WOO
Background: Our aim was to assess the relationship of the index of microvascular resistance (IMR) in left anterior descending (LAD) artery involved STEMI patients. Methods: Data of 316 STEMI patients who had undergone primary percutaneous coronary intervention (PCI) were collected from three cardiovascular centers from 2005 to 2015. In total, 246 patients with LAD STEMI were enrolled for IMR evaluation. Patients were divided into two groups respective of the cut-off IMR value of 30. All-cause mortality, left ventricular function, improvement of systolic function, and cardiac biomarkers were analyzed and compared. Results: A total of 246 patients were enrolled. The number of patients in the IMR above 30 group was 93 and below 30 was 153. The mean ages for each group were 57.91 ± 11.99 and 54 ± 10.63, respectively. The peak creatinine kinase (CK) (3936.85 ± 2827.32 IU/L vs. 2218.08 ± 2310.41 IU/L, p < 0.001) and CKmb (336.15 ± 195.08 mg/mL vs. 231.53 ± 179.53 mg/mL, p < 0.001) levels were higher for an IMR above the 30 group. The left ventricular ejection fraction (LVEF) (44.57 ± 6.685% vs. 47.35 ± 8.17%, p = 0.006) and improvement of LVEF (2.81 ± 7.135% vs. 5.88 ± 7.65%, p = 0.004) was lower in the IMR above 30 group. All-cause mortality (7.5% vs. 1.3%, p = 0.012) was higher in the IMR above 30 group, and a Cox regression analysis showed that an IMR above 30 was a poor prognostic factor regarding all-cause mortality (HR: 5.151, 95% CI 1.062–24.987, p = 0.042) even after adjusting for classical clinical risk factors. Conclusions: An elevated IMR value represented larger infarct size, more severe LV dysfunction, and higher mortality in LAD STEMI patients after successful PCI.